chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arms; This is a spontaneous report from a contactable consumer (patient) via the Pfizer-sponsored program.   A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on 23Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient already got the 2nd dose of vaccine last 23Feb2021 and until now she is experiencing sore arms. The outcome of the event was not recovered.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nauseous; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 28Feb2021 (Batch/Lot number was not reported) as dose number unknown, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the vaccine on 28Feb2021 and have been nauseous from it since the day prior. The patient wanted to know if that is a regular side effect from the vaccine and if that is normal. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Pain
Clinical narrative: Caller is still not feeling well ( chills, pain, feels tired); Caller is still not feeling well ( chills, pain, feels tired); Caller is still not feeling well ( chills, pain, feels tired); Caller is still not feeling well ( chills, pain, feels tired); This is a spontaneous report from a Pfizer-sponsored program Support from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 15Feb2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient was still not feeling well (chills, pain, feels tired) after the 1st dose of Covid-19 vaccine last 15Feb2021. Patient was scheduled for 2nd dose on 13Mar2021. The outcome of events was not recovered. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.  No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: fatigue; Headaches; muscle soreness; This is a spontaneous report from a contactable consumer (patient) from the Pfizer-sponsored program, Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fatigue, headaches and muscle soreness 4 days after the vaccine was administered on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mild muscle soreness at the injection site; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration, on an unspecified date, as dose number unknown, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date (after use of product), the patient was experiencing mild muscle soreness at the injection site. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Headache, Lethargy, Pain
Clinical narrative: achy; headache; lethargy; This is a spontaneous report from a contactable consumer.   A 69-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation.  Medical history included High blood pressure.  The patient's concomitant medications were not reported.  After the second dose, the patient felt achy, had a headache and lethargy. The patient has normal temperature. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mild injection site pain after vaccination; This is a spontaneous report from a contactable consumer or other non hcp reported for herself (patient). A 40-years-old non pregnant adult female patient (not pregnant at the time of vaccination) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 09:00 (Batch/Lot Number: EN6203) (at the age of 40-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not received any other vaccines in 4 weeks of vaccination. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 04Mar2021 at 09:15, the patient experienced mild injection site pain after vaccination and then moderate injection site pain for about 2 hours starting around 6 pm et, then went back to being mild pain, continuing with mild pain the next day. The patient did not receive any treatment for the event. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy
Clinical narrative: swollen glands; headache; This is a spontaneous report from a Pfizer sponsored program from a contactable male consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 17Feb2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced swollen glands and headache on an unspecified date with outcome of unknown. He does not like to take the second dose because he got several side effects such as swollen glands and headache. He got his first dose on 17Feb2021. He was scheduled to have his second dose on 10Mar2021. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis
Clinical narrative: Hard of hearing; This is a spontaneous report from a Pfizer-sponsored program,SUPPORT. A non-contactable consumer (patient) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, on an unspecified date, as dose 1, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first shot and needs to get scheduled for the second shot. On an unspecified date, the patient was hard of hearing. The outcome of the event was unknown. No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: slight arm discomfort; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 28Feb2021 (Batch/Lot number was not reported) (at the age of 45 years old) as dose number unknown, single for COVID-19 immunisation. Medical history included asthmatic. The patient's concomitant medications were not reported. The patient experienced slight arm discomfort (like a flu shot) on 01Mar2021. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Malaise, Vomiting
Clinical narrative: feeling very sick; watery diarrhea; throwing up; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable consumer (patient) reported that a patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 28Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got first dose yesterday evening, then on 01Mar2021 the patient was feeling very sick, has been having watery diarrhea and is throwing up. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; This is a spontaneous report from a non-contactable consumer via Pfizer sales representative. A male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced flu like symptoms. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore in her arm; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported) via an unspecified route of administration on 01Mar2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient said that she didn't have any issues or problems to report except for a little sore in her arm on an unspecified date. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm Soreness; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date in 2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced arm soreness on an unspecified date in 2021. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: body aches; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The day after receiving the first dose of BNT162B2 on an unspecified date, the patient experienced body aches for a few hours. The patient recovered from the event on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pain of skin
Clinical narrative: scalp pain; This is a spontaneous report from a non-contactable consumer (patient) via the Pfizer Sponsored Program Corporate (Pfizer) Social Media Platforms.   A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient experienced scalp pain on an unspecified date with outcome of unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Rash, Rash papular, Rash pruritic
Clinical narrative: Rash as burning, itching, bumps; Rash as burning, itching, bumps; a couple of bumps, the size of two half dollars put together on his neck, there was a raised cluster of bumps; Rash on his neck; This is a spontaneous report from a contactable consumer (patient). A 49-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EN6201), via an unspecified route, administered in left arm on 18Feb2021 at noon (at the age of 49 years) as dose 1, single for covid-19 immunization at his work. The patient's medical history was not reported. The patient's concomitant medications were reported as none. There was no other Products. There was no history of patient. He had not taken any new medications and did not have any medications to include on this report. History of all previous immunization with the Pfizer vaccine considered as suspect was not applicable. There was no additional vaccines administered on same date of the Pfizer suspect. There was no any vaccine prior vaccinations (within 4 weeks). There was none adverse events following prior vaccinations. There were no relevant tests. Patient's Medical History (including any illness at time of vaccination): The patient declined being sick at the time of vaccination. The caller is calling about the COVID 19 Pfizer vaccine. The reporter said his first dose was on 18Feb2021 and, he never linked it, but on 19Feb2021 he woke up with a rash on his neck. He said his brother showed him article he had read and it said in a few cases there were some rashes. His brother said he should call doctor, the caller called his doctor, he could not get in until next week, Thursday. He described the rash as burning, itching, bumps, and said for some reason he did not link it to the shot. He said he woke up with the rash, it was in the morning, he got up at 5. It was a lot better, sometimes it itches, there were a couple of bumps, the size of two half dollars put together on his neck, there was a raised cluster of bumps. He might be messing with it, his brother gave him the article, the caller called his doctor, he was not getting in, then said it was not like he was dying, then says well maybe he was. The second dose said Pfizer BioNTech EN6205, that was on 11Mar2021. NDC/EXP for second dose was unknown. His first dose was on the left arm, the same side the rash was on, received at noon. His second dose was in his right arm and was at 10am. The adverse events did not result into emergency room and physician office. The outcome of events was unknown.   No follow-up attempts were possible. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vulvovaginal pruritus
Clinical narrative: She has red spots on her arms and ankles. She started itching at her ankles. Then itching worked its way up her body to her arms and shoulder. It even affected her outer vagina. She itches so bad, she wants to tear her skin out. She started itching at her ankles. Then itching worked its way up her body to her arms and shoulder. It even affected her outer vagina. She itches so bad, she wants to tear her skin out.; This is a spontaneous report from a contactable consumer reported for herself that: A 79-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number was not reported) as dose 1 unknown, administered in Arm Right on Feb2021 10:00AM single dose for covid-19 immunisation. The patient medial history included flu vaccine on an unspecified date in OCT2020. The concomitant medications were not reported. On an unspecified date in Feb2021, she started itching at her ankles. Then itching worked its way up her body to her arms and shoulder. It even affected her outer vagina. she went to the gynecologist, and her doctor told her that the itching could be because of the covid vaccine.She itches so bad, she wants to tear her skin out. She has red spots on her arms and ankles. She received her second dose of the covid vaccine exactly a week later. Confirmed with caller that she received her second dose of the covid vaccine one week after she received the first dose of the covid vaccine. Patient visited physician office (gynecologist). At the time of reporting, the outcome of the events were not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Cough, Hypersensitivity, Illness, Pain in extremity, Sinusitis
Clinical narrative: They experience soreness on the arm; They both got allergies and it's like a sinus infection; we had sinus infection and coughing and anything like that; the both of us got sick; They both got allergies and it's like a sinus infection; we had sinus infection and coughing and anything like that; the both of us got sick; They both got allergies and it's like a sinus infection; we had sinus infection and coughing and anything like that; the both of us got sick; sick; This is a spontaneous report from a Pfizer-sponsored program (Support). A contactable consumer (patients wife) reported similar events for 2 patients. This was a 2nd of 2 reports. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on 30Apr2021, as a dose 1, single for COVID-19 immunization. The patient's medical history includes kidney transplant. The concomitant medications were not reported. On an unspecified date the patient experience soreness on the arm and got allergies and it's like a sinus infection. Reporter stated that the patient had antibiotic, they started antibiotic last 10May2021 and her other concern though, the reporter queried if it is okay for them to or if they can still take the second dose on 21May2021, or its okay for them to take antibiotic (Unspecified Medication).  Reporter queried that from the first shot the reporter and the patient is possible that both of got sick because of it. Reporter was informed to contact the Pfizer Medical Information. Reporter stated that they are not side effects it's the fact that we both got sick from, whether it was sinus instead we had sinus infection and coughing and anything like that but the reporter saying to you, you report in this but it this from the shot that we had. Ok, the reporter just wanted to report that both got sick, but they don't know why they got sick. Reporter stated, "their main concern was the medical part, if they can have the second shot and that's all the reporters need to know. Outcome of the events was unknown. No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Cough, Hypersensitivity, Illness, Influenza, Productive cough
Clinical narrative: little bit sick; Runny nose; I get like allergies such as sneezy; I get like allergies such as sneezy; little bit of coughy; lot of phlegm like in throat; Flu; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection, Batch/Lot number: unknown) via an unspecified route of administration on 13May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection, Batch/Lot number not reported) via an unspecified route of administration on unspecified date as DOSE 1, SINGLE for covid-19 immunisation. On an unspecified date in May2021, patient experienced little bit sick, runny nose, i get like allergies such as sneezy, little bit of coughy, lot of phlegm like in throat, flu. Patient got second dose and patient feel okay about it but recently little bit sick like you know the normal like runny nose, patient had not a fever but runny nose, patient got like allergies such as sneezy and a lot of a little bit of coughy, lot of phlegm like in throat, flu. Reporter's seriousness was unspecified for all events. The outcome of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing
Clinical narrative: little bit sick; Runny nose; I get like allergies such as sneezy; I get like allergies such as sneezy; little bit of coughy; lot of phlegm like in throat; Flu; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection, Batch/Lot number: unknown) via an unspecified route of administration on 13May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER BIONTECH COVID VACCINE, solution for injection, Batch/Lot number not reported) via an unspecified route of administration on unspecified date as DOSE 1, SINGLE for covid-19 immunisation. On an unspecified date in May2021, patient experienced little bit sick, runny nose, i get like allergies such as sneezy, little bit of coughy, lot of phlegm like in throat, flu. Patient got second dose and patient feel okay about it but recently little bit sick like you know the normal like runny nose, patient had not a fever but runny nose, patient got like allergies such as sneezy and a lot of a little bit of coughy, lot of phlegm like in throat, flu. Reporter's seriousness was unspecified for all events. The outcome of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia
Clinical narrative: she missed the 2nd dose; Fever; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable Female consumer (patient) reported that. A female patient of an unspecified age received first dose of BNT162B2 (formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 26Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported she received the 1st dose on 26Mar2021, but she missed the 2nd dose which was supposed to be on 26Apr2021 because she had a fever. She is inquiring how to reschedule the 2nd dose. Confirmed the patient received the Pfizer-BioNTech COVID-19 vaccine. Cold transferred to  due to the long wait time and Cold transferred to  due to the long wait time. Were any medical questions addressed by this program forwarded/referred to Medical Information was not applicable. The patient experienced she missed the 2nd dose and fever on an unspecified date. The clinical outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypersensitivity
Clinical narrative: stated that her son got an allergic reaction to the first dose; hard time breathing; This is a spontaneous report from a contactable Consumer reported for a patient (reporter's son) via Pfizer Sponsored Program.  A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 30Apr2021, as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received first dose on 30Apr2021 and for the second dose 28May2021. The patient mother (reporter) wanted to know the waiting period for the doses and if the second has to be taken at the same time clockwise as the first dose. She also stated that her son got an allergic reaction to the first dose and had a hard time breathing on an unspecified date. She was a little worried about receiving the second dose because she heard it was a little more intense then the first dose. The outcome of both the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 47-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Lot Number: EW0187) via an unspecified route of administration, administered in left arm on 26May2021 (at the age of 47-year-old) as dose 2, single for covid-19 immunization. Medical history included blood pressure high, outdoor allergies/allergies from an unknown date and unknown if ongoing. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for allergies, start and stop date were not reported. Historical vaccine included BNT162B2 (BNT162B2, solution for injection, Lot number: EW0167) via an unspecified route of administration in left arm, administered on 05May2021 (at the age of 47-year-old) as dose 1, single for COVID-19 immunization. On an unspecified date the patient reported after the second dose, her head was hurting on yesterday; she woke up in morning her whole body was aching and fever and chills and her head hurted really bad. Outcome of the events were unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: Fever; Hives; This is a spontaneous report received from a contactable other health care physician (patient, self-reporting). A 51-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EK9231) via intramuscular route of administration on 28Jan2021 16:15 (at the age of 51-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included estrogens esterified, methyltestosterone [Estratest] received orally for HRT (hormone replacement therapy) started on 02Jan2021 till 01Mar2021. Patient was not pregnant at the time of vaccination. Prior vaccination within 4 weeks was reported as None. Patient's medical history including any illness at time of vaccination and relevant test was reported as None. The patient experienced hives on 28Jan2021 20:00 and fever on 29Jan2021 06:00. Therapeutic measures were taken as a result of hives and fever with Ibuprofen, Acetaminophen and Benadryl. Outcome of events was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Cough, Dyspnoea, Fatigue
Clinical narrative: Difficulty breathing; chest pain and pressure; chest pain and pressure; wheezing; dry cough; constant fatigue for 7+ days so far; Arm numbness; This is a spontaneous report from a contactable consumer (patient). A 32-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm, on 28May2021 at 16:30 (at the age of 32-years-old), as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history included COVID-19. The patient previously took sulfa and experienced drug allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29May2021, the patient experienced difficulty breathing, chest pain and pressure, wheezing, dry cough, constant fatigue for seven plus days till the time of report and arm numbness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events difficulty breathing, chest pain and pressure, wheezing, dry cough, constant fatigue for seven plus days till the time of report, arm numbness was not resolved at the time of this report.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Wheezing
Clinical narrative: Difficulty breathing; chest pain and pressure; chest pain and pressure; wheezing; dry cough; constant fatigue for 7+ days so far; Arm numbness; This is a spontaneous report from a contactable consumer (patient). A 32-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm, on 28May2021 at 16:30 (at the age of 32-years-old), as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history included COVID-19. The patient previously took sulfa and experienced drug allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29May2021, the patient experienced difficulty breathing, chest pain and pressure, wheezing, dry cough, constant fatigue for seven plus days till the time of report and arm numbness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events difficulty breathing, chest pain and pressure, wheezing, dry cough, constant fatigue for seven plus days till the time of report, arm numbness was not resolved at the time of this report.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: breakout of hives on arms and abdomen area with some on the right side of face; This is a spontaneous report from a contactable consumer (patient). A 17-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration in left arm on 03Jun2021 at 18:45 (at the age of 17-years-old) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number was not reported) via an unspecified route of administration in left arm on 13May2021 at 18:45 (at the age of 17-years-old) as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 04Jun2021, the day after receiving the second dose, the patient noticed a breakout of hives on arms and abdomen area with some on the right side of face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Patient had not received any treatment for the event. The clinical outcome of the event breakout of hives on arms and abdomen area, with some on the right side of face was not recovered at the time of the report.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Pain, Pyrexia
Clinical narrative: Chills; fever; body aches; weakness; headaches; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received second dose of bnt162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: unknown) via an unspecified route of administration in the Left Arm on 04Jun2021 at 19:15 (age at vaccination: 37-year-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: unknown) via an unspecified route of administration in the Left Arm on 14May2021 at 19:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021 at 14:00 the patient experienced chills, fever, body aches, weakness and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events, chills, fever, body aches, weakness and headaches were recovering at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Influenza like illness, Pyrexia
Clinical narrative: Fever; Flu like symptoms; Joint pain; This is a spontaneous report from a contactable consumer (patient). A 17-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in right arm on 06Jun2021 at 12:30 (at the age of 17-years) as dose 2, single for COVID-19 immunization. The patient medical history included were not reported. The patient's concomitant medications included ibuprofen (IBUPROFEN). The patient had previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration in the right arm on 14May2021 at 15:45 (at the age of 16-years) as a dose 1, single for COVID-19 immunization. The patient had no known allergies. The patient had not received any other vaccines within four weeks prior to the vaccination. On 06Jun2021 at 17:30, the patient experienced joint pain; and on 06Jun2021 at 19:30 fever, flu like symptoms. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events was recovering at the time of report.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Erythema, Feeling hot, Headache
Clinical narrative: Injection site pain; Rash; Itching; Hives area of about 6" wide and 8" long; Area was hot, had swelling; Redness; Warm pain; Slight fever of 100.7; Head pain; Neck pain; Muscle pain; Joint pain; Feeling of unwellness; Area was hot; This is a spontaneous report from a contactable consumer (patient). A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration, administered in the left arm on 14Apr2021 at 11:30 (at the age of 64-years-old) as a dose 2, single for COVID-19 immunization. Medical history included blood pressure high and had unspecified known allergies. The patient has taken unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration, administered in the left arm on an unspecified date in 2021 (at the age of 64-years-old) as a dose 1, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021, the patient experienced injection site pain, rash, itching, hives area of about 6" wide and 8" long, area was hot, had swelling, redness, warm pain, slight fever of 100.7, head pain, neck pain, muscle pain, joint pain and feeling of unwellness for about one week, after the second vaccine. The patient underwent lab tests and procedures which included body temperature: 100.7 (Slight fever) on an unspecified date. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for events. The clinical outcome of all the events was recovered on an unspecified date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Neck pain, Pain, Pruritus
Clinical narrative: Injection site pain; Rash; Itching; Hives area of about 6" wide and 8" long; Area was hot, had swelling; Redness; Warm pain; Slight fever of 100.7; Head pain; Neck pain; Muscle pain; Joint pain; Feeling of unwellness; Area was hot; This is a spontaneous report from a contactable consumer (patient). A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration, administered in the left arm on 14Apr2021 at 11:30 (at the age of 64-years-old) as a dose 2, single for COVID-19 immunization. Medical history included blood pressure high and had unspecified known allergies. The patient has taken unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration, administered in the left arm on an unspecified date in 2021 (at the age of 64-years-old) as a dose 1, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021, the patient experienced injection site pain, rash, itching, hives area of about 6" wide and 8" long, area was hot, had swelling, redness, warm pain, slight fever of 100.7, head pain, neck pain, muscle pain, joint pain and feeling of unwellness for about one week, after the second vaccine. The patient underwent lab tests and procedures which included body temperature: 100.7 (Slight fever) on an unspecified date. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for events. The clinical outcome of all the events was recovered on an unspecified date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Swelling, Urticaria, Vaccination site pain
Clinical narrative: Injection site pain; Rash; Itching; Hives area of about 6" wide and 8" long; Area was hot, had swelling; Redness; Warm pain; Slight fever of 100.7; Head pain; Neck pain; Muscle pain; Joint pain; Feeling of unwellness; Area was hot; This is a spontaneous report from a contactable consumer (patient). A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration, administered in the left arm on 14Apr2021 at 11:30 (at the age of 64-years-old) as a dose 2, single for COVID-19 immunization. Medical history included blood pressure high and had unspecified known allergies. The patient has taken unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration, administered in the left arm on an unspecified date in 2021 (at the age of 64-years-old) as a dose 1, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021, the patient experienced injection site pain, rash, itching, hives area of about 6" wide and 8" long, area was hot, had swelling, redness, warm pain, slight fever of 100.7, head pain, neck pain, muscle pain, joint pain and feeling of unwellness for about one week, after the second vaccine. The patient underwent lab tests and procedures which included body temperature: 100.7 (Slight fever) on an unspecified date. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for events. The clinical outcome of all the events was recovered on an unspecified date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymph node pain, Lymphadenopathy, Nasopharyngitis, Swelling
Clinical narrative: Patient had dormant lymph nodes from early childhood. After the vaccine, they have engorged with a lot of pain, severe headaches, swelling, and cold; Patient had dormant lymph nodes from early childhood. After the vaccine, they have engorged with a lot of pain, severe headaches, swelling, and cold; Patient had dormant lymph nodes from early childhood. After the vaccine, they have engorged with a lot of pain, severe headaches, swelling, and cold; Patient had dormant lymph nodes from early childhood. After the vaccine, they have engorged with a lot of pain, severe headaches, swelling, and cold; Patient had dormant lymph nodes from early childhood. After the vaccine, they have engorged with a lot of pain, severe headaches, swelling, and cold; This is a spontaneous report from a contactable consumer, the parent. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: not reported) via an unspecified route of administration in the left arm on 24May2021 at 14:15 (at the age of 17-years-old) as a DOSE 1, SINGLE for COVID-19 immunisation. Medical history included lymph node disorder (reported as Patient had dormant lymph nodes from early childhood). The patient previously had penicillin for unknown indication and experienced penicillin allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was reported that patient had dormant lymph nodes from early childhood. On 26May2021 at 13:00, after the vaccine, they had engorged with a lot of pain, severe headaches, swelling, and cold. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.No therapeutic measures were taken as a result of the events.The clinical outcome of the events was not recovered. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding, Menstrual disorder
Clinical narrative: I have had two menstrual periods/my sister is having similar symptoms; I have been spotting now/my sister is having similar symptoms; This is a spontaneous report from a contactable Other HCP. This Other HCP reported for a female patient (reporter's sister). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. No known allergies were reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had not received any other vaccine within 4 weeks. Other medications in two weeks: Yes, too many. On an unspecified date the patient experienced I have had two menstrual periods/my sister is having similar symptoms and I have been spotting now/my sister is having similar symptoms. The reporter reported that patient did not receive treatment for events (not on any meds or birth control). The outcome for the events were unknown. Follow-up attempts are completed. No further information is expected.